Alice Swearingen
Alice Swearingen RSS

Alice is currently a Principal Industry Consultant in the CHAI organization at SAS.
Alice has more than 20 years pharmaceutical experience at GlaxoSmithKline (GSK), where she most recently served as Vice President, Channel Development and Sales. During her career at GSK she gained experience in finance, pricing, managed markets, global pricing & reimbursement, and US marketing. She has a bachelor of science degree in business administration / accounting from Auburn University. Alice currently resides in Raleigh, North Carolina

Recent Posts

Can pulling a pharmaceutical drug from a European market help you achieve optimal revenue? - Part 2

In Part 1 of my blog, I listed nine questions your global pricing team should ask to determine if they’re ready to support C-suite discussions on ... Read More

Can pulling a pharmaceutical drug from a European market help you achieve optimal revenue?

How do you make the tough decision? Gut, analytics or a combination? Is your global pricing team ready to support reference pricing decisions with your ... Read More

Launch optimization equals revenue optimization

Optimizing pharmaceutical launch price and country sequence around the globe is more complicated than it sounds, at least it is when it is done strategically ... Read More

Top 5 reasons I am looking forward to the 10th Annual SAS Health & Life Sciences Executive Conference

This week marks the 10th Annual SAS Health and Life Sciences conference in Cary with a lineup of spectacular speakers and panel participants! As part ... Read More

Are health plan leaders establishing transformation deadlines?

We all have significant deadlines in our lives marked by a date on a calendar.  Deadlines that come to mind for me this year include: ... Read More

What compelling event will move you?

I recently faced a tough decision- do I repair and revive my home air conditioning unit yet another year or do I replace it?  As ... Read More

Changing the relationship requires new efforts from pharma and plans

Whether you believe a successful relationship is a 50/50 split or 100%/100% commitment, the market has yet to see either case when viewing the pharma/payer ... Read More

"Treat" patients with big data insights

In today’s retail age of deep customer insights, targeted customer communications, and honoring customer preference in nearly every market segment, why doesn't the healthcare value ... Read More

Consumer-friendly predictive analytics are the key to making CDHPs work

The new year, filled with New Year's resolutions  and rolling your accumulated out of pocket health care expenses back to zero.  In fourth quarter last year, most employees renewed ... Read More

Advanced analytics in commercial life science, the rewards offset the risks

Over the past ten years managed markets organizations have developed their own analytical capabilities to evaluate membership, portfolio and health coverage offerings.    The results from these analytical ... Read More
  • About this blog

    Welcome to the SAS Health and Life Sciences blog. We explore how the health care ecosystem – providers, payers, pharmaceutical firms, regulators and consumers – can collaboratively use information and analytics to transform health quality, cost and outcomes.
  • Subscribe to this blog

    Enter your email address:

    Other subscription options

  • Archives